Where AI Actually Earns Its Keep at a Research Site

Every vendor at every conference is now selling AI for clinical research. Some of it works. Most of it solves a problem your site doesn't have, or solves a real problem so partially that you end up doing the work twice. Here's how to think about where automation actually earns its keep at a research site in 2025.

Start with the tasks nobody defends

The best automation candidates share three traits: they're repetitive, they follow rules a coordinator could write down, and nobody on your team would fight to keep doing them. That's a short list, and it's the right place to start.

• Inbound referral triage. Pulling name, phone, condition, and medication from a web form or a faxed referral and dropping it into your tracker. Rules-based, high volume, low judgment.
• Appointment reminders and confirmations. Text and email sequences with escalation to a live call. Sites commonly see meaningful reductions in pre-screen no-shows just from adding a second reminder at the right interval.
• Source document drafting. Templates that pre-populate visit date, protocol version, and subject ID so the coordinator writes only the clinical narrative.
• Regulatory binder tracking. Expiration monitoring for licenses, CVs, training certificates, and delegation logs.

Notice that none of these require a large language model. A lot of what gets marketed as AI is workflow automation with better branding, and that's fine — the value is real, just don't pay AI prices for it.

Where language models genuinely help

The honest use cases for generative AI at the site level cluster around unstructured text.

Chart review for pre-screening. If you have EHR access and a protocol with messy inclusion criteria — prior therapy lines, specific lab windows, comorbidity exclusions — a model that reads notes and flags likely candidates for human review saves real hours. The key phrase is for human review. Treat output as a worklist, never a determination.

Summarizing long documents. Turning a 90-page protocol into a coordinator-facing visit checklist, or drafting a plain-language description of study procedures for a recruitment ad. You will edit it. Editing is faster than starting cold.

Drafting sponsor and IRB correspondence. Deviation narratives, query responses, monitoring visit follow-ups. First drafts, always reviewed.

The questions to ask any vendor

1. Where does the data live, and is there a BAA? If PHI touches the tool, you need a signed business associate agreement and clarity on whether your data trains their model. Get that answer in writing.
2. What does the audit trail look like? Anything touching regulated records needs Part 11 controls — attributable, time-stamped, unalterable.
3. Does it write back into systems we already use? A tool that requires double entry is a net loss no matter how smart it is.
4. What happens when it's wrong? Ask for the error rate, ask how errors surface, and ask who reviews them.

Keep a human in every consequential loop

The line to hold is straightforward: automation can surface, draft, remind, and organize. It should not determine eligibility, consent a participant, or finalize a regulatory record without a named person signing off. Document that boundary in an SOP before you deploy anything, not after your first monitoring finding.

Start with one workflow. Measure coordinator hours before and after. If you can't show the difference in a month, the tool wasn't the bottleneck.